Iain Crossingham trained in respiratory and intensive care medicine in Nottingham and Manchester before being appointed as a consultant in East Lancashire in 2011. His clinical interests include mechanical ventilation, sleep medicine and airways disease. His research focusses on evaluation of respiratory treatments through systematic review and meta analysis.
He is an associate editor of the Journal of the Intensive Care Society.
Maqsood U, Ho TN, Palmer K, Eccles FJ, Munavvar M, Wang R, Crossingham I, Evans DJ. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2019 Mar 6;3:CD012930. doi: 10.1002/14651858.CD012930.pub2
Kelly C, Chalmers JD, Crossingham I, Relph N, Felix LM, Evans DJ, Milan SJ, Spencer S. Macrolide antibiotics for bronchiectasis. Cochrane Database Syst Rev. 2018 Mar 15;3:CD012406. doi: 10.1002/14651858.CD012406.pub2
Crossingham I. In defence of ward-based non-invasive ventilation. J Intensive Care Soc. 2018 Feb;19(1):4-5. doi: 10.1177/1751143717722351
Kew KM, Carr R, Crossingham I. Lay-led and peer support interventions for adolescents with asthma. Cochrane Database Syst Rev. 2017 Apr 19;4:CD012331. doi: 10.1002/14651858.CD012331.pub2
Crossingham I, Evans DJ, Halcovitch NR, Marsden PA. Stepping down the dose of inhaled corticosteroids for adults with asthma. Cochrane Database Syst Rev. 2017 Feb 1;2:CD011802. doi: 10.1002/14651858.CD011802.pub2.
Crossingham IR, Nethercott DR, Columb MO. Comparing cardiac output monitors and defining agreement: A systematic review and meta-analysis. J Intensive Care Soc. 2016 Nov;17(4):302-313. doi: 10.1177/1751143716644457.